HUMAN GENOME SCIENCES INC Operating Cash Flow
HUMAN GENOME SCIENCES INC reported Operating Cash Flow of -$130.52 million for the 6-month period ending 2012-06-30, per its 10-Q filed 2012-07-26.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2012-07-26
- HUMAN GENOME SCIENCES INC net cash provided by (used in) operating activities for the quarter ending 2012-06-30 was -$47.49M.
- HUMAN GENOME SCIENCES INC net cash provided by (used in) operating activities for the quarter ending 2012-03-31 was -$83.02M.
- HUMAN GENOME SCIENCES INC net cash provided by (used in) operating activities for the quarter ending 2011-12-31 was -$82.08M.
- HUMAN GENOME SCIENCES INC net cash provided by (used in) operating activities for the quarter ending 2011-09-30 was -$80.70M.
- HUMAN GENOME SCIENCES INC net cash provided by (used in) operating activities for fiscal 2011 was -$397.92M.
- HUMAN GENOME SCIENCES INC net cash provided by (used in) operating activities for fiscal 2010 was -$280.69M.
- HUMAN GENOME SCIENCES INC net cash provided by (used in) operating activities for fiscal 2009 was -$332.00K.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2012-06-30 | -$47.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-26 | -$130.52M 10-Q · filed 2012-07-26 | -$212.60M derived: sum of 3 quarters · filed 2012-07-26 | -$293.30M derived: sum of 4 quarters · filed 2012-07-26 |
| 2012-03-31 | -$83.02M 10-Q · filed 2012-04-26 | -$165.11M derived: sum of 2 quarters · filed 2012-04-26 | -$245.81M derived: sum of 3 quarters · filed 2012-04-26 | -$344.68M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-12-31 | -$82.08M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | -$162.78M derived: sum of 2 quarters · filed 2012-02-28 | -$261.66M derived: sum of 3 quarters · filed 2012-07-26 | -$397.92M 10-K · filed 2012-02-28 |
| 2011-09-30 | -$80.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28 | -$179.57M derived: sum of 2 quarters · filed 2012-07-26 | -$315.84M 10-Q · filed 2011-10-28 | -$394.35M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-06-30 | -$98.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-26 | -$235.13M 10-Q · filed 2012-07-26 | -$313.65M derived: sum of 3 quarters · filed 2012-07-26 | -$370.51M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-03-31 | -$136.26M 10-Q · filed 2012-04-26 | -$214.77M derived: sum of 2 quarters · filed 2012-04-26 | -$271.64M derived: sum of 3 quarters · filed 2012-04-26 | -$344.19M derived: sum of 4 quarters · filed 2012-04-26 |
| 2010-12-31 | -$78.51M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | -$135.38M derived: sum of 2 quarters · filed 2012-02-28 | -$207.93M derived: sum of 3 quarters · filed 2012-02-28 | -$280.69M 10-K · filed 2012-02-28 |
| 2010-09-30 | -$56.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28 | -$129.42M derived: sum of 2 quarters · filed 2011-10-28 | -$202.18M 10-Q · filed 2011-10-28 | |
| 2010-06-30 | -$72.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-28 | -$145.31M 10-Q · filed 2011-07-28 | ||
| 2010-03-31 | -$72.76M 10-Q · filed 2011-04-29 | |||
| 2009-12-31 | -$332.00K 10-K · filed 2012-02-28 |